BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 16,560
-70 (-0.42%)
Aug 14, 2025, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 512.11 billion as of August 14, 2025. Its market cap has decreased by -11.25% in one year.
Market Cap
512.11B
Enterprise Value
568.14B
Revenue
140.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,560.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 512.11B, an increase of 1,925.27%. That is a compound annual growth rate of 13.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 512.11B | -12.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | 828.30B | 236.18% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 38.80T |
| ALTEOGEN | 24.00T |
| Yuhan | 8,487.38B |
| Peptron | 8,130.78B |
| SK Biopharmaceuticals | 7,846.99B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,648.08B |